Unknown

Dataset Information

Experts' Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care.


ABSTRACT:

Background

Drugs and high-risk medical devices are increasingly likely to receive Food and Drug Administration (FDA) approval through expedited pathways, which has implications for informed treatment consent (i.e., consent in clinical practice).

Objective

To obtain expert opinion about the clinical and ethical implications of the increasing availability of new drugs and devices approved through expedited development and regulatory review pathways.

Design

Qualitative study using individual semi-structured videoconference interviews.

Participants

National leaders in medicine, ethics, and law (n=12) with expertise in medical product regulation, payor policymaking, bioethics, physician practice, patient advocacy, public health expertise/advocacy, clinical trials, t

SUBMITTER: Dhruva SS 

PROVIDER: S-EPMC9708961 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature